HOME > TEAM

PROFESSIONAL TEAM

Jacky Chen,Founder / Managing Partner

Education

    MBA from Cornell University (US); Bachelor from Zhongshan University

Work Experience

    With 20 years of experience in multinational companies and investment sector. Previously held the positions of Business Development Director, China Head, Investment VP and Managing Director at:

    MNCs such as A.T.Kearney, SHELL, General Electric, Philips, and Syngenta

    CXC Capital, Managing Director (200M USD fund)

    GL Capital, Senior VP (450M USD fund)

    Olympus Capital, China Head (1 billion USD fund)

Investment Cases

    Pharma: Jingfeng Pharma (IPO),PegBio, Jingfeng Pharma, Kawin, Ascentage, ArkBio, NeuPharma

    Healthcare Services: Arrail Dental, Zhejiang Kangning Hospital (IPO), FMD, JHL, BrightGene, Chiral Quest

    Medical Device: MID Labs, Scanadu, Percutek, KingstronBio, United Imaging, LenoMed, POCTech

    IVD: BGI Genomics, Creative Sciences, Life Real

Yi Lin,Ph.D. Managing Partner

Education

    MBA from University of Chicago; PhD in molecular biology from Medical College of Columbia Univ.; Bachelor in biology from Peking University

Work Experience

    Successful industrial experience, medicine and medical device investment fund investment and management experience. 

     River Head Capital: Executive Director 

    Founder Korea Investment: Managing Director 

    ePlanet Ventures: Chinese Partners
    Mingly China Growth Fund: Executive Director
    Eastwin Life Sciences: Co-founder & director 

    McKinsey:  Senior Consultant

Investment Cases

    Drug Discovery: RC-Pharmaceutical, PegBio Medicine, Yinglian Biopharmaceutical, Sorrento Pharmaceutical (Nasdaq: SRNE), EOC 

    Medical services: IKANG  (exited), Huayi Webz (exited), BeauCare Clinics,
    Medical devices: Family of Health (exited), Alltech Medical (exited), Muenster Medicine, Yongyuan Medicine 

    IVD: CaptialBio, Life Real, Shuwen, Wuhan Healthcare, iShine,

Guochun Li,Ph.D. Partner

Education

    University of Missouri, PhD in Genetics 

    University of Science and Technology, BS in Biology

Work Experience

    Executive role in China public pharma and responsible for new drug discovery and R&D, including IND Enabling and clinical PoC CMC/cGMP planning and license, BD and commercialisation etc.

    Gloria Pharma (SZ: 002437), Chief Scientist, BoD Director, R&D VP

    Biotreatment Department Head, Chief Researcher, Genetic Institute of Novartis Research Foundation

    Post-Doc researcher, Susan G. Komen Breast Cancer Foudation, UCSD

Investment Cases

    nvolved in several license in/out projects, transaction size 800M USD

Jay Yin,Partner

Education

    BEc in SUFE and MBA in IMD Lausanne

Work Experience

    10+ years experience in MedTech MNCs and investment.

    Ex- Partner at Guohe Capital

    Principal at Qiming Ventures

    Principal at Qiming Ventures

Investment Cases

    Over 10 investments made at Qiming including MicroTech, Aohua, Infervision etc. 2 cross-boarder M&As and 1 merger at MicroPort

Weipeng Gao,Partner

Education

    EMBA,CEIBS

    LLM Peking University

    BS in Economics; Beijing Technology and Business University

Work Experience

    Over 20 years experience in finance, law and investment.

    Managing Director at Eastern Link Capital

    Venture Partner at Abax Capital

    Executive Director at CXC Capital

    6 years law practice and served CDB, Xinda Asset Mgt.

    GM Assistant at Commonwealth Bank of Australia China Branch

Investment Cases

    Healthcare industry: Hengsheng Medical

    Healthcare Bio, Qihui Bio,Sinobioway Biomedicine (002581), Snibe Diagnostic. Other industries: GBS Energy,HTGH Environment,TDHX Security,HC SemiTek (300323)

Xiao Liu,Vice President

Education

    Shanghai Advanced Institute of Finance, EMBA; Georgia Tech, Health Systems and ECE, MS; Peking University Electronics, BS

Work Experience

    Since 2005, focus on medical/senior care services, health IT, health data and innovation. Btw 2006 and2016, work as a management consultant: 

    DeKalb Medical         Operation Analyst 

    Capgemini & EY        Senior Consultant 

    Dorenfest Group        China Head 

    Deloitte Monitor        Associate Director 

    Supported Intel, Philips Healthcare, CR Health, IMS, Dignity Health etc through various M&A services 

    Btw 2016 and 2019, served as Investment VP at Tahoe Health and Executive Director at Taikang Healthcare Fund 

    Independent Non-Executive Director of Health 100 and Youth Member of IT Specialist Committee of China Hospital Association

Investment Cases

    Alliance Health Services, Beijing Yuhe Hospital, Chengdu Xilian Hospital, Chengdu ASD Orthopedics Hospital

Gaojian Ning,Vice President

Education

    MS in Organic Chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences; BS in Pharmaceutical Engineering from China Pharmaceutical University

Work Experience

    Analyst at Nanjing Baojun Capital and medicinal chemist Basilea (China)

Investment Cases

    Kindor, BrightGene, PEGBio, etc

Duhua Zhou,Investment Director

Education

    BS in Clinical Medicine, Tongji Medical University. MS in Molecular Biology, Huazhong Science and Technology University

Work Experience

    R&D Manager at Chinese leading PCR diagnostics company
    Worked at Juguang Tech Strategic Investment Department and participated in several M&A project with responsibility in assessing MedTech investment opportunities 

    Worked at DIAN Diagnostics’ strategic investment department and lead several M&A projects. Lead IVD product strategic investment

Investment Cases

    Bosheng Biopharma, Shenzhen Yitong ,Biocare, Shenzhen Yahuilong, Boaosaisi etc. Bosheng is filing for IPO

Weibin Hu,Ph.D. Investment Director

Education

    Ph D in Virology from Institute Pasteur of Shanghai, Chinese Academy of Sciences; BS in Bioscience from China Agricultural University

Work Experience

    Product manager, Abbott Diagnostic China; 

    Product manager, Diasorin China; 

    Application scientist Thermo Fisher Scientific

Investment Cases

    Hao Yan MD,Investment Director

    Education

      MS in Internal Clinical Medicine from Fudan University; BS in Clinical Medicine from Fudan University

    Work Experience

      senior product specialist at Olympus, responsible for product promotion strategy, market research, and new product launch for the urology products. Before that she worked as a management trainee at the MIP department of JNJ, responsible for academic-based promotion, and new surgical procedure promotion

    Investment Cases

      Shuguo Chen,Senior Investment Manager

      Education

        MS in Engineering From Shanghai Jiaotong University

        Bachelor in Science From Shanghai Jiaotong University

      Work Experience

        Senior Engineer in MicroPort

        Head of Interventional Device Department in Hengrui Medical


      Investment Cases